TB Care in Different Life Stages and Health Conditions
TB CHOICE NOTES 8 / 9
Two people given the same positive result for latent TB infection may receive different advice about what comes next. Age, recent exposure, current conditions and medicines affect both the risk of future TB disease and the issues that need monitoring during treatment. Rather than treating someone else's experience as your prescription, ask what needs particular attention in your situation. 1 2
This article does not set the same medicine or testing schedule for everyone in a particular group. It focuses on information to share before a visit: a young child's recent exposure, an older adult's multiple medicines, diabetes care, planned immunosuppressive treatment, and pregnancy or breastfeeding plans. If treatment is already underway, report new circumstances as they arise. 2 3
1. Separate the risk of infection from the risk of disease after infection
Sharing air with someone who has infectious TB affects the likelihood of exposure to TB bacteria. Young age, some existing conditions and immunosuppressive treatments, on the other hand, can affect the likelihood of developing active TB disease after infection. A single piece of information is therefore not enough to conclude, “I did not see anyone coughing, so I do not need to discuss testing,” or “I am healthy, so I can skip contact testing.” 1
Having a risk factor is not a diagnosis of current TB disease or a finding that you can spread it. WHO distinguishes infection from disease and highlights the need to consider disease risk in children, people with diabetes and those with weakened immunity. A clinical review brings together exposure dates, test results, previous treatment, current symptoms and health conditions. 4
If the words “high risk” worry you, ask, “Are we discussing my risk of a new infection, or my risk of developing disease from an infection I already have?” The distinction helps explain why further tests or preventive treatment may be relevant to you.
2. Seek early advice after a young child's exposure, even without symptoms
Infants and young children need particular consideration because infection can progress more quickly or lead to severe forms of TB. If a family or childcare setting notifies you of exposure, do not delay advice because the child is playing normally. Tell a clinician experienced in pediatric care the child's age, last exposure date, BCG vaccination history and previous test results. 5
Testing a child is not simply a smaller version of an adult's assessment. Test selection and follow-up can vary with age and exposure, and an initial negative result may not end follow-up. For very young contacts in particular, the clinician decides whether preventive measures are needed rather than simply waiting for a repeat test. Parents should not choose tests or medicines from an age chart found online. 2
During treatment, children may find it difficult to describe how they feel. Watch for and report changes such as loss of appetite, vomiting, abdominal discomfort or yellowing of the skin or eyes. If a child cannot swallow the medicine or vomits after taking it, ask the clinician or pharmacist for individual instructions rather than giving another dose or changing the formulation yourself. 2
3. Age alone does not decide treatment for older adults
An LTBI treatment decision weighs the benefit of reducing future disease risk against the risk of adverse reactions. Older age does not automatically rule out treatment, and a positive test does not mean everyone should receive the same regimen. Recent infection, existing conditions such as liver disease, previous treatment and current medicines all need review. 2
If medicines are prescribed for hypertension, diabetes, heart disease or other conditions, combine the lists from different clinics. Liver disease and previous adverse drug reactions need to inform the pretreatment discussion and monitoring plan. The older-adult adverse-reaction examples in the Korean counseling casebook are based on clinical assessment; they are not instructions to remove medicines one at a time at home. 2
Practical information matters too: is it difficult to manage medicines alone, travel to appointments, or read or hear the instructions? If a caregiver can attend, prepare the medicine list and questions together with the person's consent. Useful questions include “Who should help check that doses are taken, and how?” and “Which number should we call about an adverse reaction?” 3
4. Coordinate TB care and blood glucose management if you have diabetes
Diabetes is associated with a greater risk of developing active TB disease after infection. This does not mean everyone with diabetes needs the same test at the same interval. Discuss the need for testing and treatment using recent exposure, symptoms and previous TB or LTBI diagnoses and treatment records. 6
Tell the TB team about diabetes medicines and the diabetes team about TB medicines. Some can affect how the others work. The two treatments need coordinated review rather than self-directed reduction or stopping of either medicine. If food intake or your general condition has changed, bring that information and any usual blood glucose records to the appointment. 2 6
If someone who previously completed adequate treatment has another positive result, diabetes alone does not automatically determine that retreatment is needed. Past records, new exposure and immune status are considered individually. Good diabetes control is also not a reason to ignore recent TB exposure or new symptoms. 2
5. Report the planned start date of immunosuppressive treatment
Treatments affecting immunity are important to discuss, including transplant-related treatment, some medicines for rheumatic conditions or inflammatory bowel disease, and corticosteroids. If the names are unfamiliar, show the prescription or injection schedule. Report not only medicines already in use but also planned medicines and their start dates, so clinicians can review the necessary assessment and sequence of care. 1 3
Do not assume a result from one department automatically reaches another. Make sure both teams can review past positive results and treatment-completion records. Whether immunosuppressive treatment should be delayed or paused, and how to coordinate it with LTBI treatment, are clinical decisions that also take the original illness into account. Do not stop either treatment yourself. 3
Report recent TB exposure and new cough, fever or weight loss as well as test results. Immune status can affect test interpretation and the need for additional assessment. “My previous test was negative” should not replace a discussion of a new situation. 9
6. Pregnancy and breastfeeding do not automatically rule out treatment
During pregnancy, first distinguish active TB disease from LTBI. If active TB disease is diagnosed, treatment needs to be planned promptly, not deferred until after birth simply because of pregnancy. Clinicians choose appropriate medicines and monitoring for the pregnant person and fetus. If you discover you are pregnant during treatment, tell the prescriber and obstetric team immediately rather than stopping medicines yourself. 7
The timing of LTBI treatment is individualized. Korean counseling guidance explains that pregnancy should not delay treatment when the risk of disease is high, such as after recent exposure to infectious TB or with weakened immunity. Starting after birth may be considered when the risk is low. Neither “No one can be treated during pregnancy” nor “Every positive result means the same medicine immediately” is appropriate. 2
Some TB treatments can be used during breastfeeding, and breastfeeding does not always have to stop. The actual medicines, the mother's infectiousness and the baby's need for assessment must each be checked. A mother taking TB medicine does not mean that her baby receives adequate TB prevention or treatment through breast milk. Give accurate information about gestational age, the birth date, breastfeeding and pregnancy plans, and do not add supplements without a prescription or clinical instruction. 3 8
Appointment checklist for your circumstances
- I have gathered recent exposure notifications, the last exposure date and previous test results.
- I have prepared records of previous TB or LTBI treatment and its completion.
- I have combined all prescription medicines, nonprescription medicines, traditional herbal medicines and supplements in one list.
- I have noted the name, start date and responsible department for planned immunosuppressive treatment.
- I have reported existing conditions such as liver disease or diabetes and previous adverse reactions.
- I have discussed pregnancy, breastfeeding and pregnancy plans, as well as help needed with medicines or visits.
Common questions
Does a child vaccinated with BCG still need contact testing?
BCG is important in protecting children from severe forms of TB, but it does not prevent every infection or case of disease. If your child receives an exposure notification, report the vaccination history and attend the recommended assessment. 2
Is LTBI treatment impossible for an older person with liver disease?
Age alone does not decide. Liver health and the risk of TB disease need to be assessed together. If treatment is chosen, ask what monitoring is needed. Enduring severe discomfort is not a way to demonstrate commitment to treatment. 2
With a positive result during pregnancy, can I wait until after birth to seek advice?
No. Active TB disease and your individual risk of developing disease need assessment first. Recent exposure or weakened immunity may change treatment timing, so seek advice when you receive the result. 2 7
Life Choice Note takeaway: The same test result can lead to different next steps. Share not only your age and medical history but also planned treatments and pregnancy plans, so TB advice fits your circumstances.
This article provides general health information and does not replace individual medical decisions about testing, treatment, pregnancy or breastfeeding. Discuss starting, stopping or changing medicines with your care team. Sources checked: 24 October 2026 KST.
Official references
- CDC, Tuberculosis Risk Factors — The distinction between exposure risk and the risk of disease after infection.
- KDCA, 2026 Standard Counseling Casebook for TB and LTBI Management (in Korean) — Including Q27, Q83, Q97, Q100, Q116 and Q127–130.
- KDCA, 2026 National Tuberculosis Control Guidelines (in Korean) — Assessment of high-risk contacts, patient support and treatment in particular circumstances. This article does not determine eligibility for coverage or assistance.
- WHO, Tuberculosis — Dated 24 March 2026; disease risk and principles of care.
- CDC, Tuberculosis in Children — Children's risk and assessment. US age-based testing guidance and regimens are not presented as a prescription table for Korea.
- CDC, TB Risk and People with Diabetes — Diabetes, disease risk and review of concurrent medicines.
- CDC, Tuberculosis in Pregnancy — Prompt treatment of active TB disease during pregnancy and individual assessment.
- CDC, Tuberculosis Clinical Care and Treatment During Pregnancy — The distinction between breastfeeding and treatment of an infant.
- CDC, Clinical Testing Guidance: Interferon Gamma Release Assay — Limitations of a negative result with weakened immunity or recent infection.
